NCT01510730View on ClinicalTrials.gov

Helicobacter Pylori Eradication After Endoscopic Resection of Gastric Tumors

PHASE3CompletedINTERVENTIONAL
Enrollment

855

Participants

Timeline

Start Date

January 31, 2005

Primary Completion Date

February 28, 2011

Study Completion Date

February 28, 2011

Conditions
Gastric TumorHelicobacter PyloriEndoscopic ResectionMetachronous Neoplasms
Interventions
DRUG

eradication treatment of Helicobacter pylori infection

Eradication group receive Omeprazole sodium 20mg, amoxicillin 1g, clarithromycin 500mg orally at the same time twice daily for 7 days.

Trial Locations (1)

110-744

Department of Internal Medicine and Liver Research Institute, Seoul National University Hospital, Seoul

All Listed Sponsors
lead

Seoul National University Hospital

OTHER

NCT01510730 - Helicobacter Pylori Eradication After Endoscopic Resection of Gastric Tumors | Biotech Hunter | Biotech Hunter